(Bloomberg) -- AstraZeneca Plc Chief Executive
Officer David Brennan, who spent $16.2 billion on purchases since
taking over, says he'll continue buying to fill the drugmaker's
product pipeline.
Brennan, 53, became CEO of London-based AstraZeneca in
January 2006, when he beat former Chief Financial Officer Jon
Symonds. Brennan and Symonds, who unexpectedly resigned June 6,
have bought four companies to bring in experimental medicines
after the failure of four drugs in late stages of testing.
Read more at Bloomberg Stocks News
Officer David Brennan, who spent $16.2 billion on purchases since
taking over, says he'll continue buying to fill the drugmaker's
product pipeline.
Brennan, 53, became CEO of London-based AstraZeneca in
January 2006, when he beat former Chief Financial Officer Jon
Symonds. Brennan and Symonds, who unexpectedly resigned June 6,
have bought four companies to bring in experimental medicines
after the failure of four drugs in late stages of testing.
Read more at Bloomberg Stocks News
No comments:
Post a Comment